Nerve Defect Treatment with a Capping Hydroxyethyl Cellulose/Soy Protein Isolate Sponge Conduit for Painful Neuroma Prevention

Painful neuroma, as one of the complications of nerve injury from disease or trauma, results in instinctive neuropathic pain that adversely affects a patient’s quality of life. To intercept neuroma development, capping strategies have been performed as effective therapies. Nonetheless, the most appr...

Full description

Saved in:
Bibliographic Details
Published inACS omega Vol. 8; no. 34; pp. 30850 - 30858
Main Authors Dong, Qi, Ai, Junjie, Xiao, Ao, Wu, Ping, Wu, Minhao, Liu, Xijing, Huselstein, Céline, Cai, Lin, Feng, Xiaolin, Chen, Yun
Format Journal Article
LanguageEnglish
Published American Chemical Society 29.08.2023
ACS Publications
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Painful neuroma, as one of the complications of nerve injury from disease or trauma, results in instinctive neuropathic pain that adversely affects a patient’s quality of life. To intercept neuroma development, capping strategies have been performed as effective therapies. Nonetheless, the most appropriate biocompatible material to shield the nerves is an urgent clinical requirement. Herein, a compatible hydroxyethyl cellulose (HEC)/soy protein isolate (SPI) sponge capping conduit (HSSC) is used to prevent neuroma in vivo. Following capping on the sciatic nerve stump in vivo, the behavior of the rats and the structure of tissues are compared through histological assessment and autotomy scoring. The HSSCs gained a dismal autotomy score and enhanced the amelioration, where inflammatory invasions and overdeposition of collagen are defeated. The expression of myelin growth linked genes (Krox20, MPZ, and MAG) in the HSSC group at the eighth week was almost 2 times higher than that of the no capping group. The HSSC conduit served as a physical barrier to repress the infiltration of inflammation as well as provided an optimum microenvironment for facilitating nerve rejuvenation and intercepting neuroma development during nerve amelioration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC10468986
ISSN:2470-1343
2470-1343
DOI:10.1021/acsomega.3c00613